Cliff Asness’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Buy
46,323
+13,856
+43% +$840K ﹤0.01% 2323
2026
Q1
$1.8M Buy
32,467
+6,158
+23% +$331K ﹤0.01% 2422
2025
Q4
$1.28M Buy
26,309
+135
+0.5% +$5.26K ﹤0.01% 2417
2025
Q3
$801K Sell
26,174
-1,548
-6% -$35.5K ﹤0.01% 2561
2025
Q2
$615K Sell
27,722
-2,289
-8% -$47.9K ﹤0.01% 2493
2025
Q1
$558K Buy
30,011
+18,165
+153% +$303K ﹤0.01% 2365
2024
Q4
$157K Sell
11,846
-36,746
-76% -$890K ﹤0.01% 2711
2024
Q3
$1.63M Buy
+48,592
New +$1.66M ﹤0.01% 1590
2024
Q2
Sell
-24,328
Closed -$548K 2601
2024
Q1
$548K Buy
24,328
+7,646
+46% +$181K ﹤0.01% 1931
2023
Q4
$357K Buy
+16,682
New +$288K ﹤0.01% 2006
2022
Q2
Sell
-38,833
Closed -$961K 2178
2022
Q1
$961K Sell
38,833
-169
-0.4% -$5.12K ﹤0.01% 1562
2021
Q4
$1.35M Buy
39,002
+12,657
+48% +$401K ﹤0.01% 1402
2021
Q3
$714K Buy
26,345
+11,712
+80% +$297K ﹤0.01% 1726
2021
Q2
$379K Sell
14,633
-8,541
-37% -$205K ﹤0.01% 1980
2021
Q1
$499K Sell
23,174
-36,894
-61% -$931K ﹤0.01% 1837
2020
Q4
$1.29M Buy
+60,068
New +$1.46M ﹤0.01% 1386
2019
Q1
Sell
-4,442
Closed -$283K 2163
2018
Q4
$283K Sell
4,442
-8,045
-64% -$598K ﹤0.01% 1982
2018
Q3
$1.25M Sell
12,487
-20,938
-63% -$1.74M ﹤0.01% 1611
2018
Q2
$2.38M Buy
33,425
+16,185
+94% +$1.36M ﹤0.01% 1347
2018
Q1
$1.79M Buy
+17,240
New +$1.94M ﹤0.01% 1402

Other funds holding ANAB

Cliff Asness's ANAB Position: Q2 2026 in Review

Cliff Asness increased its AnaptysBio (ANAB) stake by 43% in Q2 2026, buying an estimated $840K and bringing the position to 46,323 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Cliff Asness first reported a position in ANAB in Q1 2018 and has held it in 20 quarters since. 211 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Cliff Asness held 46,323 shares of AnaptysBio worth $3.13M as of Q2 2026.
  • Cliff Asness bought 13,856 AnaptysBio shares in Q2 2026, an estimated $840K.
  • AnaptysBio made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2323 holding.
  • Cliff Asness first reported a position in AnaptysBio in Q1 2018 and has held it in 20 quarters since.
  • 211 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.